B2M and pulmonary fibrosis: These findings indicate that serum β2M levels may serve as a new indicator to assess pulmonary diffusion function and pulmonary fibrosis severity in clinical practice, and suggest that β2M may serve as a novel potential intervention target for the treatment of pulmonary fibrosis.